BusinessImmuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)By Nasdaq OMXAug 9, 2017, 12:30 PM UTC
BusinessSteraMist™ Contributes to Substantial Reduction in Clostridium Difficile Burden in HospitalBy Nasdaq OMXApr 3, 2017, 8:05 PM UTC
BusinessTOMI™ Takes Lead on Fight Against C. diff With “List K” ListingBy Nasdaq OMXMar 13, 2017, 12:01 PM UTC
BusinessTOMI™ Takes Lead on Fight Against C. diff With “List K” ListingBy Nasdaq OMXMar 13, 2017, 12:01 PM UTC
